{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:36:10Z","timestamp":1788903370755,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijpharm.2015.02.070","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T03:04:06Z","timestamp":1425092646000},"page":"108-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway"],"prefix":"10.1016","volume":"485","author":[{"given":"Shilpa","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.R.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-3525","authenticated-orcid":false,"given":"Amit K.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2015.02.070_bib0005","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","volume":"8","author":"Ali Khan","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02652048.2013.788090","article-title":"Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution","volume":"31","author":"Beloqui","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejps.2013.09.022","article-title":"Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium","volume":"51","author":"Borkar","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ijpharm.2015.02.070_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1061186X.2014.950664","article-title":"Recent approaches of lipid-based delivery system for lymphatic targeting via oral route","volume":"22","author":"Chaudhary","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpb.2013.07.017","article-title":"Solid lipid particles for oral delivery of peptide and protein drugs I \u2013 elucidating the release mechanism of lysozyme during lipolysis","volume":"85","author":"Christophersen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/17425247.2014.891014","article-title":"Biomaterial-based scaffolds \u2013 current status and future directions","volume":"11","author":"Garg","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/2210304x11202040003","article-title":"Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus","volume":"2","author":"Garg","year":"2012","journal-title":"Drug Deliv. Lett."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013007259","article-title":"Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery","volume":"30","author":"Garg","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0045","first-page":"1","article-title":"Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery","author":"Garg","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejps.2005.07.011","article-title":"Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability","volume":"26","author":"Gershkovich","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2013.855277","article-title":"Development and characterization of niosomal gel for topical delivery of benzoyl peroxide","author":"Goyal","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/21691401.2014.951721","article-title":"Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery","author":"Hallan","year":"2014","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10837450.2014.996900","article-title":"Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy","author":"Han","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0070","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijpharm.2014.10.059","article-title":"Administration strategies for proteins and peptides","volume":"477","author":"Ibraheem","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2010.06.008","article-title":"Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies","volume":"80","author":"Jia","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/16.5.366","article-title":"Some methods of electron microscopic visualization of lipoproteins in plasma and chyle","volume":"16","author":"Jones","year":"1968","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2014.993486","article-title":"Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box\u2013Behnken design","author":"Kaur","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0090","first-page":"1","article-title":"Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs","author":"Kaur","year":"2014","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-2275(20)38850-7","article-title":"Dietary supplementation with Pluronic L-81 modifies hepatic secretion of very low density lipoproteins in the rat","volume":"27","author":"Manowitz","year":"1986","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpb.2007.07.006","article-title":"Cyclosporine-loaded solid lipid nanoparticles (SLN\u00ae): drug\u2013lipid physicochemical interactions and characterization of drug incorporation","volume":"68","author":"M\u00fcller","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0105","doi-asserted-by":"crossref","first-page":"E1258","DOI":"10.1152\/ajpendo.2000.279.6.E1258","article-title":"A new method for the study of chylomicron kinetics in vivo","volume":"279","author":"Park","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2011.01.021","article-title":"Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration","volume":"79","author":"Roger","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2014.945018","article-title":"Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting","author":"Rohilla","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0169-409X(91)90047-G","article-title":"Gastrointestinal lymphatic absorption of peptides and proteins","volume":"7","author":"Rubas","year":"1991","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12645-013-0032-9","article-title":"Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer","volume":"4","author":"Vohra","year":"2013","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhazmat.2012.02.043","article-title":"Characterization of surface hydrophobicity of engineered nanoparticles","volume":"215\u2013216","author":"Xiao","year":"2012","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.ijpharm.2015.02.070_bib0140","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/mp100124f","article-title":"A modified physiological BCS for prediction of intestinal absorption in drug discovery","volume":"7","author":"Zaki","year":"2010","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T22:18:12Z","timestamp":1651357092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517315001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0378517315001982"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.070","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}